Blocking immunoinhibitory receptor LILRB2 reprograms tumor-associated myeloid cells and promotes antitumor immunity

Huiming Chen(Guizhou Academy of Sciences), Shu‐Hsia Chen(Houston Methodist)
Journal of Clinical Investigation
October 22, 2018
Cited by 262


Related Papers